Singapore vs Trinidad and Tobago: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
Singapore
97.0%
in 2025
Trinidad and Tobago
97.0%
in 2025
Singapore rank
33rd
Trinidad and Tobago rank
33rd
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- Singapore
- Trinidad and Tobago
How they compare
Singapore currently reports 97.0% against 97.0% in Trinidad and Tobago, a difference of 0.0%.
The two have swapped places 9 times across 26 shared years of data; in 2000 it was Singapore ahead.
Singapore ranks 33rd and Trinidad and Tobago ranks 33rd of 194 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Singapore | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.1% | 91.7% | 4.4% | Singapore |
| 2010s | 96.5% | 93.1% | 3.4% | Singapore |
| 2020s | 97.5% | 95.0% | 2.5% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), Singapore or Trinidad and Tobago?
- Singapore, at 97.0% against 97.0% in Trinidad and Tobago as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between Singapore and Trinidad and Tobago?
- 0.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Trinidad and Tobago?
- 26 years are reported by both, from 2000 to 2025.
- How do Singapore and Trinidad and Tobago rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Singapore ranks 33rd and Trinidad and Tobago ranks 33rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.